Minireview: MIRomics in Endocrinology: A Novel Approach for Modeling Endocrine Diseases

par Szabó, Péter M., Butz, Henriett, Igaz, Péter, Rácz, Károly, Hunyady, László, Patócs, Attila
Publié dans Mol Endocrinol (2013)

miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1

par Butz, Henriett, Szabó, Peter M., Khella, Heba W.Z., Nofech-Mozes, Roy, Patocs, Attila, Yousef, George M.
Publié dans Oncotarget (2015)

Integrative analysis of neuroblastoma and pheochromocytoma genomics data

par Szabó, Peter M, Pintér, Miklós, Szabó, Diana Rita, Zsippai, Adrienn, Patócs, Attila, Falus, András, Rácz, Károly, Igaz, Peter
Publié 2012

mRNA and microRNA expression patterns in adrenocortical cancer

par Zsippai, Adrienn, Szabó, Diana Rita, Szabó, Peter M, Tömböl, Zsófia, Bendes, Melinda R, Nagy, Zoltán, Rácz, Károly, Igaz, Peter
Publié 2011

Nivolumab in Patients with Advanced Platinum-Resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275

par Galsky, Matthew D., Saci, Abdel, Szabo, Peter M., Han, G. Celine, Grossfeld, Gary, Collette, Sandra, Siefker-Radtke, Arlene, Necchi, Andrea, Sharma, Padmanee
Publié dans Clin Cancer Res (2020)

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC

par Ross-Macdonald, Petra, Walsh, Alice M, Chasalow, Scott D, Ammar, Ron, Papillon-Cavanagh, Simon, Szabo, Peter M, Choueiri, Toni K, Sznol, Mario, Wind-Rotolo, Megan
Publié dans J Immunother Cancer (2021)

Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies

par Módos, Dezső, Bulusu, Krishna C., Fazekas, Dávid, Kubisch, János, Brooks, Johanne, Marczell, István, Szabó, Péter M., Vellai, Tibor, Csermely, Péter, Lenti, Katalin, Bender, Andreas, Korcsmáros, Tamás
Publié dans NPJ Syst Biol Appl (2017)

Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer

par Wang, Li, Gong, Yixuan, Saci, Abdel, Szabo, Peter M., Martini, Alberto, Necchi, Andrea, Siefker-Radtke, Arlene, Pal, Sumanta, Plimack, Elizabeth R., Sfakianos, John P., Bhardwaj, Nina, Horowitz, Amir, Farkas, Adam M., Mulholland, David, Fischer, Bruce S., Oh, William K., Sharma, Padmanee, Zhu, Jun, Galsky, Matthew D.
Publié dans Eur Urol (2019)

Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix

par Kemenesi, Gábor, Zeghbib, Safia, Somogyi, Balázs A, Tóth, Gábor Endre, Bányai, Krisztián, Solymosi, Norbert, Szabo, Peter M, Szabó, István, Bálint, Ádám, Urbán, Péter, Herczeg, Róbert, Gyenesei, Attila, Nagy, Ágnes, Pereszlényi, Csaba István, Babinszky, Gergely Csaba, Dudás, Gábor, Terhes, Gabriella, Zöldi, Viktor, Lovas, Róbert, Tenczer, Szabolcs, Kornya, László, Jakab, Ferenc
Publié dans Viruses (2020)

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

par Wang, Li, Saci, Abdel, Szabo, Peter M., Chasalow, Scott D., Castillo-Martin, Mireia, Domingo-Domenech, Josep, Siefker-Radtke, Arlene, Sharma, Padmanee, Sfakianos, John P., Gong, Yixuan, Dominguez-Andres, Ana, Oh, William K., Mulholland, David, Azrilevich, Alex, Hu, Liangyuan, Cordon-Cardo, Carlos, Salmon, Hélène, Bhardwaj, Nina, Zhu, Jun, Galsky, Matthew D.
Publié dans Nat Commun (2018)

Randomized trial of oral cyclophosphamide and veliparib in high-grade serous ovarian, primary peritoneal, or fallopian tube cancers, or BRCA-mutant ovarian cancer

par Kummar, Shivaani, Oza, Amit M., Fleming, Gini F., Sullivan, Daniel M., Gandara, David R., Naughton, Michael J., Villalona-Calero, Miguel A., Morgan, Robert J., Szabo, Peter M., Youn, Ahrim, Chen, Alice P., Ji, Jiuping, Allen, Deborah E., Lih, Chih-Jian, Mehaffey, Michele G., Walsh, William D., McGregor, Paul M., Steinberg, Seth M., Williams, Paul M., Kinders, Robert J., Conley, Barbara A., Simon, Richard M., Doroshow, James H.
Publié dans Clin Cancer Res (2015)

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

par Skoulidis, Ferdinandos, Goldberg, Michael E., Greenawalt, Danielle M., Hellmann, Matthew D., Awad, Mark M., Gainor, Justin F., Schrock, Alexa B., Hartmaier, Ryan J., Trabucco, Sally E., Gay, Laurie, Ali, Siraj M., Elvin, Julia A., Singal, Gaurav, Ross, Jeffrey S., Fabrizio, David, Szabo, Peter M., Chang, Han, Sasson, Ariella, Srinivasan, Sujaya, Kirov, Stefan, Szustakowski, Joseph, Vitazka, Patrik, Edwards, Robin, Bufill, Jose A., Sharma, Neelesh, Ou, Sai-Hong I., Peled, Nir, Spigel, David R., Rizvi, Hira, Aguilar, Elizabeth Jimenez, Carter, Brett W., Erasmus, Jeremy, Halpenny, Darragh F., Plodkowski, Andrew J., Long, Niamh M., Nishino, Mizuki, Denning, Warren L., Galan-Cobo, Ana, Hamdi, Haifa, Hirz, Taghreed, Tong, Pan, Wang, Jing, Rodriguez-Canales, Jaime, Villalobos, Pamela A., Parra, Edwin R., Kalhor, Neda, Sholl, Lynette M., Sauter, Jennifer L., Jungbluth, Achim A., Mino-Kenudson, Mari, Azimi, Roxana, Elamin, Yasir Y., Zhang, Jianjun, Leonardi, Giulia C., Jiang, Fei, Wong, Kwok-Kin, Lee, J. Jack, Papadimitrakopoulou, Vassiliki A., Wistuba, Ignacio I., Miller, Vincent A., Frampton, Garrett M., Wolchok, Jedd D., Shaw, Alice T., Jänne, Pasi A., Stephens, Philip J., Rudin, Charles M., Geese, William J., Albacker, Lee A., Heymach, John V.
Publié dans Cancer Discov (2018)